| Losartan/Hydrochlorothiazide Krka 50 mg/12.5 mg film-coated tablets PA1347/040/001 |
Losartan potassium, Hydrochlorothiazide |
KRKA, d.d., Novo mesto |
Marketed |
| Loxentia 20mg hard gastro-resistant capsule PA1347/051/001 |
Duloxetine |
KRKA, d.d., Novo mesto |
Marketed |
| Loxentia 40mg hard gastro-resistant capsule PA1347/051/003 |
Duloxetine |
KRKA, d.d., Novo mesto |
Marketed |
| Marixino 10 mg film-coated tablets EU/1/13/820/001-013 |
Memantine hydrochloride |
KRKA, d.d., Novo mesto |
— |
| Marixino 20 mg film-coated tablets EU/1/13/820/014-026 |
Memantine hydrochloride |
KRKA, d.d., Novo mesto |
— |
| Mixtard EU/1/02/231/003-35,37 |
Insulin human, Insulin human |
Novo Nordisk A/S |
— |
| Mixtard EU/1/02/231/1-25 |
Insulin human |
Novo Nordisk A/S |
Not marketed |
| Monovo 1 mg/g Cream PA1548/002/001 |
Mometasone furoate |
Almirall Hermal GmbH |
Not marketed |
| Montelukast 10 mg film-coated tablets PA1347/039/003 |
Montelukast |
KRKA, d.d., Novo mesto |
Marketed |
| Montelukast 4 mg chewable tablets PA1347/039/001 |
Montelukast |
KRKA, d.d., Novo mesto |
Marketed |
| Montelukast 5 mg chewable tablets PA1347/039/002 |
Montelukast |
KRKA, d.d., Novo mesto |
Marketed |
| Nimvastid 1.5 mg hard capsules EU/1/09/525/1-7 |
Rivastigmine hydrogen tartrate |
KRKA, d.d., Novo mesto |
— |
| Nimvastid 1.5 mg orodispersible tablets EU/1/09/525/26-31 |
Rivastigmine hydrogen tartrate |
KRKA, d.d., Novo mesto |
— |
| Nimvastid 3 mg hard capsules EU/1/09/525/008-013 |
Rivastigmine hydrogen tartrate |
KRKA, d.d., Novo mesto |
— |
| Nimvastid 3 mg orodispersible tablets EU/1/09/525/32-36 |
Rivastigmine hydrogen tartrate |
KRKA, d.d., Novo mesto |
— |
| Nimvastid 4.5 mg hard capsules EU/1/09/525/14-19 |
Rivastigmine hydrogen tartrate |
KRKA, d.d., Novo mesto |
— |
| Nimvastid 4.5 mg orodispersible tablets EU/1/09/525/37-41 |
Rivastigmine hydrogen tartrate |
KRKA, d.d., Novo mesto |
— |
| Nimvastid 6 mg hard capsules EU/1/09/525/20-25 |
Rivastigmine hydrogen tartrate |
KRKA, d.d., Novo mesto |
— |
| Nimvastid 6 mg orodispersible tablets EU/1/09/525/42-46 |
Rivastigmine hydrogen tartrate |
KRKA, d.d., Novo mesto |
— |
| Nolpacid 20 mg gastro-resistant tablets PA1347/032/001 |
Pantoprazole |
KRKA, d.d., Novo mesto |
Not marketed |
| Nolpaza 20 mg gastro-resistant tablets PA1347/006/001 |
Pantoprazole |
KRKA, d.d., Novo mesto |
Marketed |
| Nolpaza 40 mg gastro-resistant tablets PA1347/006/002 |
Pantoprazole |
KRKA, d.d., Novo mesto |
Marketed |
| Nolxado 10 mg/5 mg prolonged-release tablets PA1347/085/001 |
OXYCODONE HYDROCHLORIDE, Naloxone hydrochloride dihydrate |
KRKA, d.d., Novo mesto |
Not marketed |
| Nolxado 20 mg/10 mg prolonged-release tablets PA1347/085/002 |
OXYCODONE HYDROCHLORIDE, Naloxone hydrochloride dihydrate |
KRKA, d.d., Novo mesto |
Not marketed |
| Nolxado 40 mg/20 mg prolonged-release tablets PA1347/085/003 |
OXYCODONE HYDROCHLORIDE, Naloxone hydrochloride dihydrate |
KRKA, d.d., Novo mesto |
Not marketed |
| Norditropin FlexPro 10 mg/1.5 ml, solution for injection in pre-filled pen PA0218/040/012 |
Somatropin |
Novo Nordisk A/S |
Marketed |
| Norditropin FlexPro 15 mg/1.5 ml, solution for injection in pre-filled pen PA0218/040/013 |
Somatropin |
Novo Nordisk A/S |
Marketed |
| Norditropin FlexPro 5 mg/1.5 ml, solution for injection in pre-filled pen PA0218/040/011 |
Somatropin |
Novo Nordisk A/S |
Marketed |
| NovoEight 1000 IU powder and solvent for solution for injection EU/1/13/888/003 |
Turoctocog alfa |
Novo Nordisk A/S |
— |
| NovoEight 1500 IU powder and solvent for solution for injection EU/1/13/888/004 |
Turoctocog alfa |
Novo Nordisk A/S |
— |
| NovoEight 2000 IU powder and solvent for solution for injection EU/1/13/888/005 |
Turoctocog alfa |
Novo Nordisk A/S |
— |
| NovoEight 250 IU powder and solvent for solution for injection EU/1/13/888/001 |
Turoctocog alfa |
Novo Nordisk A/S |
— |
| NovoEight 3000 IU powder and solvent for solution for injection EU/1/13/888/006 |
Turoctocog alfa |
Novo Nordisk A/S |
— |
| NovoEight 500 IU powder and solvent for solution for injection EU/1/13/888/002 |
Turoctocog alfa |
Novo Nordisk A/S |
— |
| Novofem film-coated tablets PA0218/053/001 |
Estradiol, Norethisterone acetate, Estradiol |
Novo Nordisk A/S |
Marketed |
| NovoMix 30 FlexPen 100 units/ml suspension for injection in pre-filled pen EU/1/00/142/09-010 |
Insulin aspart |
Novo Nordisk A/S |
— |
| NovoMix 30 Penfill 100 units/ml suspension for injection in cartridge EU/1/00/142/004-05 |
Insulin aspart |
Novo Nordisk A/S |
— |
| NovoMix 50 FlexPen 100 units/ml suspension for injection in pre-filled pen EU/1/00/142/14-16 |
Insulin aspart |
Novo Nordisk A/S |
— |
| NovoMix 50 Penfill 100 units/ml suspension for injection in cartridge EU/1/00/142/11-13 |
Insulin aspart |
Novo Nordisk A/S |
— |
| NovoNorm 0.5 mg tablets EU/1/98/076/004 |
Repaglinide |
Novo Nordisk A/S |
— |
| NovoNorm 0.5 mg tablets EU/1/98/076/005 |
Repaglinide |
Novo Nordisk A/S |
— |
| NovoNorm 0.5 mg tablets EU/1/98/076/006 |
Repaglinide |
Novo Nordisk A/S |
— |
| NovoNorm 0.5 mg tablets EU/1/98/076/007 |
Repaglinide |
Novo Nordisk A/S |
— |
| NovoNorm 1 mg tablets EU/1/98/076/011 |
Repaglinide |
Novo Nordisk A/S |
— |
| NovoNorm 1 mg tablets EU/1/98/076/012 |
Repaglinide |
Novo Nordisk A/S |
— |
| NovoNorm 1 mg tablets EU/1/98/076/013 |
Repaglinide |
Novo Nordisk A/S |
— |
| NovoNorm 1 mg tablets EU/1/98/076/014 |
Repaglinide |
Novo Nordisk A/S |
— |
| NovoNorm 2 mg tablets EU/1/98/076/018 |
Repaglinide |
Novo Nordisk A/S |
— |
| NovoNorm 2 mg tablets EU/1/98/076/019 |
Repaglinide |
Novo Nordisk A/S |
— |
| NovoNorm 2 mg tablets EU/1/98/076/020 |
Repaglinide |
Novo Nordisk A/S |
— |